First-line avelumab plus axitinib combination shows promising efficacy in advanced kidney cancer
Results from an early phase Ib clinical trial of avelumab [...]
Pazopanib for the treatment of von Hippel-Lindau disease
The results from a phase II clinical trial, which demonstrates [...]
New drug epacadostat plus pembrolizumab combination shows promise in patients with advanced kidney cancer
The results from a phase I/II clinical trial of epacadostat [...]
Scientists discover a genetic cause of childhood kidney cancer
Scientists at The Institute of Cancer Research (ICR), London, and [...]
UK’s first high-energy proton beam therapy for cancer in Wales
The first high-energy proton beam therapy system to be installed [...]
Lack of physical activity increases the risk of bladder and kidney cancer
A recent study published in the journal Cancer Epidemiology by [...]
Adjuvant therapy for high-risk localised kidney cancer
This literature review was published in The Journal of Urology [...]
Nivolumab shows a substantial response in people with metastatic non-clear cell kidney cancer
Nivolumab has demonstrated a substantial objective response rate and was [...]
Waist measurements can predict risk of cancer
A recent study published in the British Journal of Cancer [...]
Cancer diagnoses in England reach an all-time high
Recently published data from the Office for National Statistics (ONS) [...]
